Short description
Biopharmaceutical company. developing targeted immunotherapies and vaccine products for a wide range of resilient diseases.
Description
Etubics Corporation is a Seattle based biopharmaceutical company developing targeted immunotherapies and vaccine products for a wide range of resilient diseases.
Etubics patent-protected technology has been proven to be safer, more efficient and more effective than current vectored vaccines and gene delivery platforms.
Total funding
$$3123123
Sign in for full access
Location
Seattle, Washington, United States, North America
Founded on
January 1, 2003
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Uh Ohhhh
Sign in for full access
Founders
Frank R. Jones